The Oncology Institute “Prof. Dr I. Chiricuta” Cluj-Napoca (IOCN), was founded in 1929 by Prof. Dr. Iuliu Moldovan under the name of “Institute for Cancer Prophylaxis and Treatment” and is one of the first medical centers in Europe, being also the first large research unit that took as its main objective “the study of cancer prophylaxis” at a time when the very notion of prophylaxis was vaguely defined.
IOCN provides preventive, curative and palliative medical services in the field of oncology, with more than 25,000 patients treated each year. The Institute focuses on extensive investigations in fundamental sciences and prevention, diagnostic and therapeutic strategies. The Institute coordinates basic, clinical, translational and population research. It is a source of innovation and it developed an integrated platform for research, patient care and teaching for the benefit of our patients, for their well-being and a better quality of life.
It is a dedicated cancer centre with multiple cancer treatment departments and clinical wards comprising 597 beds. The most important Oncology Institute from Romania, member of The Organisation of European Cancer Institutes (OECI) since 2008, the Institute has been certified in November 2017 as “Clinical Cancer Centre”.
Being the Regional Management Unit for Screening Program and host institution of the NW Regional Cancer Registry, the Institute hosts a group of experts in epidemiology, public health, health economics, gynaeco-oncology and colposcopy, family doctors, data managers and registrars.
The Breast Tumor Center, surgery, radiotherapy and chemotherapy services, the Department of Nuclear Medicine (the only institution in Romania accredited by the UEMS – European Union of Medical Specialists), the Laboratory of Genetics, Genomics and Experimental Pathology, the Laboratory of Radiobiology and Tumor Biology are a small selection of the many services found in the teams of doctors and researchers at the Oncology Institute of Cluj-Napoca.
Organisation role in the consortium
–
